Caladrius Biosciences Inc - ESG Rating & Company Profile powered by AI
Scroll down to the end of this page for potential risks for Caladrius Biosciences Inc based on sector, geography and marketcap. The Disclosure rating covers seventeen UN SDGs including: 'Clean Water & Sanitation', 'Reduced Inequalities' and 'Peace, Justice & Strong Institutions'. Alternative companies in the scoring peer group for Caladrius Biosciences Inc are shownin the table.
Caladrius Biosciences Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 8.0; made up of an environmental score of 8.0, social score of 8.0 and governance score of 8.0.
8.0
High ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 1 | CK Life Sciences Intl (Holdings) Inc | 8.0 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Caladrius Biosciences Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Caladrius Biosciences Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Caladrius Biosciences Inc report the average age of the workforce?
Sign up for free to unlockDoes Caladrius Biosciences Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Caladrius Biosciences Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Caladrius Biosciences Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Caladrius Biosciences Inc offer flexible work?
Sign up for free to unlockDoes Caladrius Biosciences Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Caladrius Biosciences Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Caladrius Biosciences Inc conduct supply chain audits?
Sign up for free to unlockDoes Caladrius Biosciences Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Caladrius Biosciences Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Caladrius Biosciences Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Caladrius Biosciences Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Caladrius Biosciences Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Caladrius Biosciences Inc disclose water use targets?
Sign up for free to unlockDoes Caladrius Biosciences Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Caladrius Biosciences Inc have a product recall in the last two years?
Sign up for free to unlockDoes Caladrius Biosciences Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Caladrius Biosciences Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Caladrius Biosciences Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Caladrius Biosciences Inc disclose parental leave metrics?
Sign up for free to unlockDoes Caladrius Biosciences Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Caladrius Biosciences Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Caladrius Biosciences Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Caladrius Biosciences Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Caladrius Biosciences Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Caladrius Biosciences Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Caladrius Biosciences Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Caladrius Biosciences Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Caladrius Biosciences Inc disclose its waste policy?
Sign up for free to unlockDoes Caladrius Biosciences Inc report according to TCFD requirements?
Sign up for free to unlockDoes Caladrius Biosciences Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Caladrius Biosciences Inc disclose energy use targets?
Sign up for free to unlockDoes Caladrius Biosciences Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Caladrius Biosciences Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Caladrius Biosciences Inc
These potential risks are based on the size, segment and geographies of the company.
Caladrius Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient of SAKIGAKE designation that is in Phase II clinical trial for the treatment of critical limb ischemia; OLOGO, a regenerative medicine advanced therapy for treating no-option refractory disabling angina; CLBS16 that is in Phase IIb clinical trial for the treatment of coronary microvascular dysfunction; and CLBS201, a CD34+ cell therapy for the treatment of pre-dialysis patients with chronic kidney disease. The company was formerly known as NeoStem, Inc. and changed its name to Caladrius Biosciences, Inc. in June 2015. Caladrius Biosciences, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.